Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

441
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

88
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
88
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

576
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
576
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

140
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
140
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

111
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
111
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

89
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidimensional Profiles of Recovery: Using Correspondence Analysis to Visualize Physiotherapy Outcomes in Patients with Chronic Low Back Pain.

Journal of clinical medicine·2026
Same author

EUROHELICAN-The First Helicobacter Pylori Screen-and-Treat Population-Based Study in Young Adults in Europe.

United European gastroenterology journal·2026
Same author

EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication.

Helicobacter·2026
Same author

Machine Learning in Primary Health Care: The Research Landscape.

Healthcare (Basel, Switzerland)·2025
Same author

Prevalence of Sarcopenia Among Slovenian Older Adults and Associated Risk Factors.

Zdravstveno varstvo·2025
Same author

Lipoprotein(a) as a Risk Factor for Recurrent Acute Myocardial Infarction and Mortality: Insights from Routine Clinical Practice.

Diagnostics (Basel, Switzerland)·2024

Related Experiment Video

Updated: Nov 5, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

622

Supporting Real World Decision Making in Coronary Diseases Using Machine Learning.

Peter Kokol1, Jan Jurman1, Tajda Bogovič1

  • 1Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia.

Inquiry : a Journal of Medical Care Organization, Provision and Financing
|May 17, 2021
PubMed
Summary

Machine learning algorithms show higher accuracy in real-world clinical data for coronary artery disease diagnosis. Decision trees and neural networks excel with noisy, routinely collected data, outperforming models trained on cleaner datasets.

Keywords:
artificial intelligencecardiovascular conditionscross-validationdecision makingdiagnosingheuristicsknowledge discoverymachine learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Related Experiment Videos

Last Updated: Nov 5, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

622
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Area of Science:

  • Cardiology and Medical Informatics
  • Application of Artificial Intelligence in Healthcare

Background:

  • Cardiovascular diseases represent a significant global health burden.
  • Machine learning algorithms (MLA) show promise in medical decision-making.
  • Previous studies often utilize cleansed datasets, lacking 'real-world noise'.

Purpose of the Study:

  • To assess machine learning's utility in supporting coronary artery disease diagnosis.
  • To evaluate MLA performance on routinely collected, 'noisy' clinical data.
  • To identify optimal MLAs for real-world cardiovascular databases.

Main Methods:

  • A two-phase study was conducted using the Anonymous Cardiovascular Database (ACD) and the UCI Heart Disease Dataset.
  • Phase 1: Trained and validated MLAs on the UCI dataset to establish baseline accuracy (ACU) and select optimal models.
  • Phase 2: Applied selected MLAs to the ACD, a hospital-derived, real-world dataset, to assess performance on noisy data.

Main Results:

  • Seven MLAs were selected, achieving a standard ACU of 0.85 on the UCI dataset.
  • The same MLAs achieved significantly higher ACUs, around 0.96, on the ACD.
  • Decision trees and neural networks demonstrated superior performance on the ACD, while linear regression and AdaBoost performed best on the UCI dataset.

Conclusions:

  • Machine learning algorithms perform differently on 'clean' versus 'noisy' clinical data.
  • Decision trees and neural networks are better suited for handling real-world clinical data noise.
  • These MLAs can effectively support clinical decision-making for coronary artery diseases using routinely collected data.